Growing community of inventors

Silver Spring, MD, United States of America

Yangmin Ning

Average Co-Inventor Count = 8.64

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Yangmin NingLeonard M Neckers (3 patents)Yangmin NingMarc Cox (3 patents)Yangmin NingJane B Neckers (3 patents)Yangmin NingYeong Sang Kim (3 patents)Yangmin NingHeather A Balsiger (3 patents)Yangmin NingAki Iwai (3 patents)Yangmin NingRobert J Fletterick (2 patents)Yangmin NingJohanny Kugelman-Tonos (2 patents)Yangmin NingJane B Trepel (1 patent)Yangmin NingJohanny Tonos De Leon (1 patent)Yangmin NingMarc B Cox (1 patent)Yangmin NingAki Iwai (1 patent)Yangmin NingJohanny Meneses De Leon (1 patent)Yangmin NingYangmin Ning (3 patents)Leonard M NeckersLeonard M Neckers (14 patents)Marc CoxMarc Cox (9 patents)Jane B NeckersJane B Neckers (7 patents)Yeong Sang KimYeong Sang Kim (5 patents)Heather A BalsigerHeather A Balsiger (3 patents)Aki IwaiAki Iwai (3 patents)Robert J FletterickRobert J Fletterick (7 patents)Johanny Kugelman-TonosJohanny Kugelman-Tonos (2 patents)Jane B TrepelJane B Trepel (2 patents)Johanny Tonos De LeonJohanny Tonos De Leon (1 patent)Marc B CoxMarc B Cox (1 patent)Aki IwaiAki Iwai (1 patent)Johanny Meneses De LeonJohanny Meneses De Leon (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The University of Texas System (3 from 5,450 patents)

2. The United States of America, As Represented by the Secretary, Department of Health and Human Services (3 from 3,539 patents)

3. University of California (2 from 15,475 patents)


3 patents:

1. 9782399 - Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

2. 9233973 - Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

3. 8859207 - Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…